Literature DB >> 2025953

Immunoblotting human C4 bound to human erythrocytes in vivo and in vitro.

C M Giles1, T Robson.   

Abstract

A study of C4 bound to human erythrocytes in vitro and in vivo has been made by immunoblotting with mouse monoclonal anti-C4c and anti-C4d and human polyclonal anti-C4d (Rodgers and Chido) following SDS-PAGE. Multi-banded patterns differentiated between C4A and C4B isotypes. Treatment of EC4b with trypsin eliminated immunoblotting but not agglutination reactions. Serum inactivation (factor I) of EC4b resulted in banding patterns similar to those obtained from patients' EC4d. Treatment of EC4b membranes with NH2OH affected many of the bands, two were lost, one was markedly reduced and others had altered SDS-PAGE mobility. Interpretation of the bands has been made in terms of C4-acceptor complexes and inactivation fragments of C4. A distinct difference in the banding of C4A and C4B isotypes has been detected.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2025953      PMCID: PMC1535384          DOI: 10.1111/j.1365-2249.1991.tb08159.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Interaction between the third complement protein and cell surface macromolecules.

Authors:  S K Law; R P Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

2.  A study of HLA (Bg) on red cells and platelets by immunoblotting with monoclonal antibodies.

Authors:  C M Giles; M Botto; M J King
Journal:  Transfusion       Date:  1990-02       Impact factor: 3.157

3.  Localisation of Chido and Rodgers determinants to the C4d fragment of human C4.

Authors:  C A Tilley; D G Romans; M C Crookston
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

4.  Chido and Rogers antigenic determinant on the fourth component of human complement.

Authors:  V F Chu; W L Marsh; I Gigli
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

5.  Differential coating of human red blood cells with C4 or C3 in a low ionic strength medium.

Authors:  H E Heier; L Kornstad; R Nordhagen
Journal:  Vox Sang       Date:  1981       Impact factor: 2.144

6.  Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.

Authors:  S K Law; N A Lichtenberg; F H Holcombe; R P Levine
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

7.  The C4 beta-chain: evidence for a genetically determined polymorphism.

Authors:  G Mauff; M Steuer; M Weck; K Bender
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

8.  Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator.

Authors:  S Nagasawa; C Ichihara; R M Stroud
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

Review 9.  Antigenic determinants of human C4, Rodgers and Chido.

Authors:  C M Giles
Journal:  Exp Clin Immunogenet       Date:  1988

10.  Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator.

Authors:  T Fujita; I Gigli; V Nussenzweig
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.